RxSight, Inc. Payments of Stock Issuance Costs
RxSight, Inc. (RXST) reported Payments of Stock Issuance Costs of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsOfStockIssuanceCosts · last filed 2026-02-25
- RxSight, Inc. payments of stock issuance costs for the quarter ending 2025-12-31 was $0.00.
- RxSight, Inc. payments of stock issuance costs for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- RxSight, Inc. payments of stock issuance costs for the quarter ending 2024-12-31 was $0.00.
- RxSight, Inc. payments of stock issuance costs for the quarter ending 2024-09-30 was $391.00K, a 768.89% increase year-over-year.
- RxSight, Inc. payments of stock issuance costs for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- RxSight, Inc. payments of stock issuance costs for fiscal 2024 was $768.00K, a 23.47% increase from fiscal 2023.
- RxSight, Inc. payments of stock issuance costs for fiscal 2023 was $622.00K, a 5.96% increase from fiscal 2022.
- RxSight, Inc. payments of stock issuance costs for fiscal 2022 was $587.00K.
| Period end | Payments of Stock Issuance Costs 3 month | Payments of Stock Issuance Costs 6 month | Payments of Stock Issuance Costs 9 month | Payments of Stock Issuance Costs 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $0.00 derived: sum of 2 quarters · filed 2026-02-25 | $0.00 10-K · filed 2026-02-25 | |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $0.00 10-Q · filed 2025-11-05 | ||
| 2025-06-30 | $0.00 10-Q · filed 2025-08-07 | |||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $391.00K derived: sum of 2 quarters · filed 2026-02-25 | $768.00K derived: sum of 3 quarters · filed 2026-02-25 | $768.00K 10-K · filed 2026-02-25 |
| 2024-09-30 | $391.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $768.00K derived: sum of 2 quarters · filed 2025-11-05 | $768.00K 10-Q · filed 2025-11-05 | $743.00K derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-06-30 | $377.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $377.00K 10-Q · filed 2025-08-07 | $352.00K derived: sum of 3 quarters · filed 2026-02-25 | $397.00K derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-06 | -$25.00K derived: sum of 2 quarters · filed 2026-02-25 | $20.00K derived: sum of 3 quarters · filed 2026-02-25 | $392.00K derived: sum of 4 quarters · filed 2026-02-25 |
| 2023-12-31 | -$25.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $20.00K derived: sum of 2 quarters · filed 2026-02-25 | $392.00K derived: sum of 3 quarters · filed 2026-02-25 | $622.00K 10-K · filed 2026-02-25 |
| 2023-09-30 | $45.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $417.00K derived: sum of 2 quarters · filed 2024-11-07 | $647.00K 10-Q · filed 2024-11-07 | $939.00K derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-06-30 | $372.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | $602.00K 10-Q · filed 2024-08-05 | $894.00K derived: sum of 3 quarters · filed 2025-02-25 | $1.19M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-03-31 | $230.00K 10-Q · filed 2024-05-06 | $522.00K derived: sum of 2 quarters · filed 2025-02-25 | $817.00K derived: sum of 3 quarters · filed 2025-02-25 | $817.00K derived: sum of 4 quarters · filed 2025-02-25 |
| 2022-12-31 | $292.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $587.00K derived: sum of 2 quarters · filed 2025-02-25 | $587.00K derived: sum of 3 quarters · filed 2025-02-25 | $587.00K 10-K · filed 2025-02-25 |
| 2022-09-30 | $295.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $295.00K derived: sum of 2 quarters · filed 2023-11-09 | $295.00K 10-Q · filed 2023-11-09 | $53.00K derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | $0.00 10-Q · filed 2023-08-07 | -$242.00K derived: sum of 3 quarters · filed 2023-08-07 | -$242.00K derived: sum of 4 quarters · filed 2023-08-07 |
| 2022-03-31 | $0.00 10-Q · filed 2023-05-09 | -$242.00K derived: sum of 2 quarters · filed 2023-05-09 | -$242.00K derived: sum of 3 quarters · filed 2023-05-09 | |
| 2021-12-31 | -$242.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | -$242.00K derived: sum of 2 quarters · filed 2023-03-06 | $0.00 10-K · filed 2023-03-06 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | $242.00K 10-Q · filed 2022-11-07 | ||
| 2021-06-30 | $242.00K 10-Q · filed 2022-08-08 | |||
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $0.00 10-Q · filed 2021-11-10 | ||
| 2020-06-30 | $0.00 10-Q · filed 2021-09-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Innovative Eyewear Inc (LUCY) | United States | $0.008B | |
| STAAR SURGICAL CO (STAA) | United States | $0.957B | 362.70 |
| National Vision Holdings, Inc. (EYE) | United States | $1.297B | |
| Warby Parker Inc. (WRBY) | United States | $2.970B | |
| Bausch & Lomb Corp (BLCO) | Canada | $6.008B | -34.58 |
| COOPER COMPANIES, INC. (COO) | United States | $10.533B | 24.09 |